Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic studyGELDERBLOM, H; BLAY, J. Y; MARREAUD, S et al.European journal of cancer (1990). 2014, Vol 50, Num 2, pp 388-396, issn 0959-8049, 9 p.Article

Interleukin-6 is a survival factor for committed myeloid progenitor cellsKERST, J. M; SLAPER-CORTENBACH, I. C. M; VAN DER SCHOOT, C. E et al.Experimental hematology. 1993, Vol 21, Num 12, pp 1550-1557, issn 0301-472XArticle

Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesisKERST, J. M; SLAPER-CORTENBACH, I. C. M; VON DEM BORNE, A. E. G. K et al.Experimental hematology. 1992, Vol 20, Num 10, pp 1188-1193, issn 0301-472XArticle

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)THEODORE, C; SKONECZNA, I; BODROGI, I et al.Annals of oncology. 2008, Vol 19, Num 7, pp 1304-1307, issn 0923-7534, 4 p.Article

α4β1 and α5β1 are differentially expresed during myelopoiesis and mediate the adherence of human CD34⁺ cells to fibronectin in an activation-dependent wayKERST, J. M; SANDERS, J. B; SLAPER-CORTENBACH, I. C. M et al.Blood. 1993, Vol 81, Num 2, pp 344-351, issn 0006-4971Article

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancerNIEUWENHUIJZEN, J. A; BEX, A; MEINHARDT, W et al.The Journal of urology. 2005, Vol 174, Num 1, pp 80-85, issn 0022-5347, 6 p.Article

Granulocyte colony-stimulating factor induces hFcγRI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cellsKERST, J. M; VAN DE WINKEL, J. G. J; EVANS, A. H et al.Blood. 1993, Vol 81, Num 6, pp 1457-1464, issn 0006-4971Article

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072KASPER, B; SLEIJFER, S; LITIERE, S et al.Annals of oncology. 2014, Vol 25, Num 3, pp 719-724, issn 0923-7534, 6 p.Article

E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endotheliumROOD, P. M. L; DERCKSEN, M. W; CAZEMIER, H et al.Annals of hematology (Print). 2000, Vol 79, Num 9, pp 477-484, issn 0939-5555Article

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers : induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cellsKERST, J. M; DE HAAS, M; VAN DER SCHOOT, C. E et al.Blood. 1993, Vol 82, Num 11, pp 3265-3272, issn 0006-4971Article

Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature reviewBEX, A; SONKE, G. S; POS, F. J et al.Annals of oncology. 2010, Vol 21, Num 11, pp 2240-2245, issn 0923-7534, 6 p.Article

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis : a phase II studyKERST, J. M; BEX, A; MALLO, H et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 9, pp 926-931, issn 0340-7004, 6 p.Article

Granulocyte colony-stimulating factor administration to healthy volunteers : analysis of the immediate activating effects on circulating neutrophilsDE HAAS, M; KERST, J. M; VAN DER SCHOOT, C. E et al.Blood. 1994, Vol 84, Num 11, pp 3885-3894, issn 0006-4971Article

Local production of interleukin-6 during acute rejection in human renal allograftsRAASVELD, M. H. M; WEENING, J. J; KERST, J. M et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 1, pp 75-78, issn 0931-0509Article